MENU
+Compare
RIGL
Stock ticker: NASDAQ
AS OF
Apr 24 closing price
Price
$19.06
Change
+$0.90 (+4.96%)
Capitalization
340.54M

RIGL Rigel Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases... Show more

Industry: #Biotechnology
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RIGL with price predictions
Apr 24, 2025

RIGL's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for RIGL turned positive on April 17, 2025. Looking at past instances where RIGL's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RIGL's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 22, 2025. You may want to consider a long position or call options on RIGL as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RIGL advanced for three days, in of 247 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RIGL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RIGL broke above its upper Bollinger Band on April 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RIGL entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RIGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RIGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (103.093) is normal, around the industry mean (14.237). P/E Ratio (19.253) is within average values for comparable stocks, (63.881). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.827). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.880) is also within normal values, averaging (255.011).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a clinical-stage drug development company that discovers and develops novel, small-molecule drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 650 624-1100
Employees
147
Web
https://www.rigel.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUCX17.830.23
+1.31%
NYLI PineStone U.S. Equity Class C
APDWX10.150.08
+0.79%
Artisan Value Income Advisor
PREJX26.94N/A
N/A
Principal Real Estate Securities J
FSTRX30.05N/A
N/A
Federated Hermes MDT Large Cap Value A
ESMSX15.16N/A
N/A
Invesco EQV Euro Small Company R6

RIGL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been loosely correlated with MNMD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RIGL jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+4.96%
MNMD - RIGL
39%
Loosely correlated
+5.24%
KYMR - RIGL
38%
Loosely correlated
+9.32%
APGE - RIGL
37%
Loosely correlated
+1.42%
TRDA - RIGL
36%
Loosely correlated
+2.87%
WVE - RIGL
36%
Loosely correlated
N/A
More